Polaryx Therapeutics, Inc. (PLYX) stock
PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.60−0.07 (-4.19%)
Close on Nov 17, 2026Market cap $79.75MP/E –Yield –
Polaryx Therapeutics cash
Cash and short-term investments held at the end of each period.
Polaryx Therapeutics's cash was $8.44M at Sep 30, 2026. For fiscal 2025 it was $5.14M, up 11.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.14M | +11.3% |
| FY2024 | Dec 31, 2024 | $4.62M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.44M | +82.6% |
| Q2 FY2026 | Jun 30, 2026 | $11.54M | – |
| Q1 FY2026 | Mar 31, 2026 | $3.08M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.14M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.62M | – |
See a number that looks wrong?